Mohsen Chiani

1.6k total citations
66 papers, 1.2k citations indexed

About

Mohsen Chiani is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Mohsen Chiani has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Biomaterials and 15 papers in Pharmaceutical Science. Recurrent topics in Mohsen Chiani's work include Nanoparticle-Based Drug Delivery (17 papers), Advancements in Transdermal Drug Delivery (14 papers) and RNA Interference and Gene Delivery (8 papers). Mohsen Chiani is often cited by papers focused on Nanoparticle-Based Drug Delivery (17 papers), Advancements in Transdermal Drug Delivery (14 papers) and RNA Interference and Gene Delivery (8 papers). Mohsen Chiani collaborates with scholars based in Iran, United States and Canada. Mohsen Chiani's co-authors include Mohammad Reza Mehrabi, Azim Akbarzadeh, Dariush Norouzian, Ali Akbar Farhangi, M. Soltani, Iman Akbarzadeh, Mohammad Souri, Farshad Moradi Kashkooli, Zahra Saffari and Mohammad Kiani Shahvandi and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Molecules.

In The Last Decade

Mohsen Chiani

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohsen Chiani Iran 21 360 349 277 195 187 66 1.2k
Chung Kil Song South Korea 19 260 0.7× 465 1.3× 247 0.9× 134 0.7× 341 1.8× 28 1.2k
Shuangquan Gou China 19 380 1.1× 294 0.8× 381 1.4× 121 0.6× 159 0.9× 30 1.1k
Swati Gupta India 22 318 0.9× 231 0.7× 178 0.6× 110 0.6× 280 1.5× 64 1.4k
May S. Freag Egypt 19 450 1.3× 424 1.2× 328 1.2× 141 0.7× 380 2.0× 22 1.5k
Roudayna Diab France 13 334 0.9× 339 1.0× 250 0.9× 192 1.0× 230 1.2× 16 1.1k
Bader M. Aljaeid Saudi Arabia 17 453 1.3× 352 1.0× 301 1.1× 173 0.9× 528 2.8× 27 1.4k
Pallabita Chowdhury United States 18 300 0.8× 332 1.0× 253 0.9× 87 0.4× 97 0.5× 31 962
Clara I. Colino Spain 14 159 0.4× 341 1.0× 212 0.8× 185 0.9× 132 0.7× 20 945
Qixiong Zhang China 16 287 0.8× 344 1.0× 317 1.1× 197 1.0× 137 0.7× 33 1.0k
Fanfei Meng China 16 259 0.7× 306 0.9× 262 0.9× 144 0.7× 131 0.7× 31 923

Countries citing papers authored by Mohsen Chiani

Since Specialization
Citations

This map shows the geographic impact of Mohsen Chiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Chiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Chiani more than expected).

Fields of papers citing papers by Mohsen Chiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohsen Chiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Chiani. The network helps show where Mohsen Chiani may publish in the future.

Co-authorship network of co-authors of Mohsen Chiani

This figure shows the co-authorship network connecting the top 25 collaborators of Mohsen Chiani. A scholar is included among the top collaborators of Mohsen Chiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohsen Chiani. Mohsen Chiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ajdary, Soheila, et al.. (2025). Immunogenic evaluation of LptD + LtgC as a bivalent vaccine candidate against Neisseria gonorrhoeae. Journal of Translational Medicine. 23(1). 261–261. 2 indexed citations
2.
Esmaeili, Saber, Mohammad Reza Asadi Karam, Ehsan Mostafavi, et al.. (2025). Development of a multi-epitope vaccine from outer membrane proteins and identification of novel drug targets against Francisella tularensis: an In Silico approach. Frontiers in Immunology. 16. 1479862–1479862. 4 indexed citations
3.
4.
Chiani, Mohsen, Babak Asghari, Ghodratollah Roshanaei, et al.. (2024). Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections. BMC Biotechnology. 24(1). 47–47. 16 indexed citations
5.
Chiani, Mohsen, et al.. (2022). Electrosprayed cefazolin‐loaded niosomes onto electrospun chitosan nanofibrous membrane for wound healing applications. Journal of Biomedical Materials Research Part B Applied Biomaterials. 110(8). 1814–1826. 35 indexed citations
6.
Mehrabi, Mohammad Reza, Dariush Norouzian, Mohammad Ali Shokrgozar, et al.. (2017). Pegylated niosomal nanoparticles loaded with vincristine: Characterization and in vitro evaluation. Tropical Journal of Pharmaceutical Research. 16(5). 975–980. 8 indexed citations
7.
Chiani, Mohsen, Dariush Norouzian, Mohammad Ali Shokrgozar, et al.. (2017). Folic acid conjugated nanoliposomes as promising carriers for targeted delivery of bleomycin. Artificial Cells Nanomedicine and Biotechnology. 46(4). 757–763. 38 indexed citations
8.
Akbarzadeh, Azim, et al.. (2015). To evaluate the effect of formulation of Nanoarchaeosomal 6-gingerol on the growth of breast cancer MCF-7 cell line. 5(19). 47–52. 6 indexed citations
9.
Chiani, Mohsen, et al.. (2014). Evaluation the cytotoxicity of nanoliposomal artemisinin on breast cancer cell line. 4(13). 99–103. 6 indexed citations
10.
Chiani, Mohsen, et al.. (2013). EVALUATING THE EFFECT OF NANOLIPOSOMAL HYDROXYUREA UREA ON THE BREAST CANCER CELL LINE. 3(11). 63–67. 1 indexed citations
11.
Chiani, Mohsen, et al.. (2013). Making paclitaxel nanoliposomal and evaluating its effect on the MCF-7. 3(10). 67–71. 1 indexed citations
12.
Chamani, Mohammad, et al.. (2012). Evaluation of the Antibacterial Properties of Silver Nanoparticles synthesized with Fusarium Oxysporum and Escherichia coli. 2(6). 27–33. 8 indexed citations
13.
Zali, Narges, Seyed Reza Mohebbi, Mohsen Chiani, et al.. (2011). Prevalence of ATP7B Gene Mutations in Iranian Patients With Wilson Disease. Hepatitis Monthly. 11(11). 890–894. 16 indexed citations
14.
Naderi, Nosratollah, Manijeh Habibi, Homayoun Zojaji, et al.. (2011). NOD2 exonic variations in Iranian Crohn's disease patients. International Journal of Colorectal Disease. 26(6). 775–781. 9 indexed citations
15.
Zali, Narges, Seyed Reza Mohebbi, Mohsen Chiani, et al.. (2011). Prevalence of ATP7B Gene Mutations in Iranian Patients With Wilson Disease. Hepatitis Monthly. 11(11). 890–894. 12 indexed citations
16.
Zojaji, Homayon, et al.. (2010). NOD2 Gene Exonic Variations in Iranian Patients with Crohn's Disease. 15(1). 12–18.
17.
Farhangi, Ali Akbar, et al.. (2010). Improved Production of L-lysine by Over-expression of Meso-diaminopimelate Decarboxylase Enzyme of Corynebacterium glutamicum in Escherichia coli. Pakistan Journal of Biological Sciences. 13(10). 504–508. 1 indexed citations
18.
Zali, Narges, Seyed Reza Mohebbi, Farzad Firouzi, et al.. (2009). Mutation spectrum of 7 exons of ATP7B gene in Iranian patients with Wilson disease. 1(1).
19.
Zojaji, Homayon, Seyed Reza Mohebbi, Mohsen Chiani, et al.. (2009). Evaluation of Global Genome Methylation in Gastritis Lesion and its Correlation With Clinicopatological Findings. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 17(11). 549–558. 9 indexed citations
20.
Bayat, Behnaz, Shahin Yazdani, Afagh Alavi, et al.. (2008). Contributions of MYOC and CYP1B1 mutations to JOAG.. PubMed. 14. 508–17. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026